This week we highlight herd immunity challenges, concerns about waiving patent protections on COVID-19 vaccines, using machine learning to reduce trial risks and more. … READ MORE >
FDA
5 things to know in life sciences: Week of April 26
This week we highlight why people may be skipping their second COVID-19 dose, challenges of AI in patient diagnosis, the evolution of the regulatory environment for biopharma companies and more. … READ MORE >
5 things to know in life sciences: Week of April 19
This week our senior analysts highlight FDA approval decisions, venture funds focused on life sciences, newly approved remote patient monitoring devices and more. … READ MORE >
5 things to know in life sciences: Week of April 5
This week we highlight vaccine mandate considerations, the lack of diversity on the boards of life sciences companies, a promising new class of drugs and more. … READ MORE >
5 things to know in life sciences: Week of March 22
This week we highlight AstraZeneca-Oxford COVID-19 vaccine challenges, FDA trends, drug-pricing reform hearings and more. … READ MORE >
Coronavirus disrupts the pipeline for new drugs and medical devices
On Tuesday, a day before the World Health Organization declared the coronavirus outbreak a pandemic, the Food and Drug Administration announced that it was postponing foreign inspections through April. … READ MORE >